Context Therapeutics Inc. - Common Stock - Nakit Akışı (NASDAQ:CNTX) | MetaTrader

Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

İşletme faaliyetlerinden elde edilen nakit -8.8 M-13.55 M-21.05 M-14.56 M-26.39 M -32.79 M Yatırım faaliyetlerinden elde edilen nakit -250 K-536.84 K0-14.76 M-2.03 M -2.04 M Finansman faaliyetlerinden elde edilen nakit 58.39 M-102.07 K0109.29 M-15.27 K 0 Serbest nakit akışı -8.8 M-13.55 M-21.05 M-14.56 M-26.42 M -32.82 M

Haberler

Neogen, Jennifer Evans Stacey’i hukuk müdürü olarak atadı

Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - BioAtla (NASDAQ:BCAB), ChowChow Cloud Internatio (AMEX:CHOW)

This Blacksky Technology Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - AirJoule Technologies (NASDAQ:AIRJ), BlackSky Technology (NYSE:BKSY)

Step Pharma appoints Karen Smith as chief medical officer

This Synopsys Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday - Context Therapeutics (NASDAQ:CNTX), Absci (NASDAQ:ABSI)

Rare Stock Picks In June 2025 - From 26 Discerning Analysts

Context Therapeutics: Undervalued Cancer Fighter (NASDAQ:CNTX)

Citizens JMP affirms $4 price target on Context Therapeutics stock

Context Therapeutics Announces CTIM-76 Trial in Progress Poster Presentation at 2025 ASCO Meeting

Citizens JMP highlights key ASCO presentations

Centrexion Therapeutics stock hits 52-week low at $0.55

Citizens JMP highlights bispecific antibodies progress